Stellar(US) | $2,700,000 | (Jan 9, 2025)
XyloCor Therapeutics, Inc. | $67,500,000 | (Jan 9, 2025)
Aspect Biosystems | $115,000,000 | (Jan 9, 2025)
VitVio
United Kingdom
- London
- 09/01/2025
- Pre-Seed
- $2,000,000
Autonomously track and analyze surgical procedures, tool usage, and processes in real-time with computer vision and AI - increasing the number of surgeries performed per day, reducing delays, improving communication actionability, and reducing the likelihood of readmissions.
Developed by a team with deep expertise in computer visio
- Industry Hospital & Health Care
- Website https://www.vitvio.com/
- LinkedIn https://www.linkedin.com/company/vitvio/
Related People
Thomas KnoxFounder
United Kingdom -
London, England
The Founder and CEO of VitVio, bringing computer vision to the surgical operating theater, creating solutions that improve patient outcomes and surgical efficiency.
I have extensive experience leading multidisciplinary teams of engineers, designers, and researchers, leveraging my expertise in AI, IoT, and human-centered design to deliver cutting-edge products.
Previously served as the Global Vice President of Product at VusionGroup and was overseeing the product portfolio and strategy for five core business units, ranging from IoT devices to computer vision and AI. Under my leadership, we achieved the first year with 12-month order entries to €1 billion, up 40% year-on-year.
I was also previously an executive at AiFi and Kiwi.com where I lead product and innovation respectively.
UNLISTED | $2,250,000 | (Jan 9, 2025)
Red Rover Health, Inc. | $4,000,000 | (Jan 9, 2025)
Deep Vector | $1,500,000 | (Jan 9, 2025)